Compare RS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RS | NBIX |
|---|---|---|
| Founded | 1939 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 13.9B |
| IPO Year | 1996 | 1996 |
| Metric | RS | NBIX |
|---|---|---|
| Price | $303.77 | $131.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 22 |
| Target Price | ★ $328.50 | $175.27 |
| AVG Volume (30 Days) | 302.0K | ★ 804.3K |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | N/A | ★ 41.95 |
| EPS | ★ 13.98 | 4.67 |
| Revenue | ★ $14,805,900,000.00 | $161,626,000.00 |
| Revenue This Year | $9.32 | $22.85 |
| Revenue Next Year | $1.11 | $10.36 |
| P/E Ratio | ★ $21.57 | $27.59 |
| Revenue Growth | N/A | ★ 977.51 |
| 52 Week Low | $250.07 | $84.23 |
| 52 Week High | $365.59 | $160.18 |
| Indicator | RS | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 53.84 |
| Support Level | $287.99 | $128.03 |
| Resistance Level | $335.13 | $136.74 |
| Average True Range (ATR) | 7.31 | 3.14 |
| MACD | 1.47 | 0.38 |
| Stochastic Oscillator | 76.96 | 79.50 |
Reliance Inc operates a network of companies providing diversified metal solutions and is the metals service center company. It distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium and other specialty steel products. The company services more than 125,000 customers in a variety of industries, including consumer products, general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, industrial machinery and heavy industry. It also services the auto industry, through its toll processing operations where it processes customer-owned metal for a fee.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.